Laverock Therapeutics appoints Ali Elsey as Finance Director Laverock Therapeutics appoints Ali Elsey as Finance Director She joins from Acacia Pharma Group plc, where she was Group Financial Controller Quotient Sciences appoints three new executive members Quotient Sciences appoints three new executive members The appointments include Andrew Lewis as Chief Scientific Officer, Kieron Hall as Chief Marketing Officer, and Eric Bironneau as Chief Business Officer Kindeva Drug Delivery appoints Jennifer Riter as Vice President of Analytical Services Kindeva Drug Delivery appoints Jennifer Riter as Vice President of Analytical Services Riter comes to Kindeva from West Pharmaceutical, where she spent the past 27 years in various technical and leadership roles Cellevate appoint Uwe Gottschalk as new Chair of Board Directors Cellevate appoint Uwe Gottschalk as new Chair of Board Directors With over 30 years of biotech experience under his belt, Dr Gottschalk will replace Mats Leifland as Chair of Cellevate AB Change in management at Hoffman Neopac AG Change in management at Hoffman Neopac AG Mark Aegler has decided to leave the company after 13 years Faller Packaging announces appointment of new CEO Faller Packaging announces appointment of new CEO Dr Michael Faller and Dr Daniel Keesman will retire in the second half of 2024 and be succeeded by Dagmar Schmidt Phastar VP Prof. Jennifer Visser-Rogers named in Women in Data Twenty in Data & Technology Phastar VP Prof. Jennifer Visser-Rogers named in Women in Data Twenty in Data & Technology Prof Visser-Rogers chosen for showcase of inspirational, trailblazing and dedicated women in data and tech Zenas BioPharma appoints Patricia Allen to its Board of Directors Zenas BioPharma appoints Patricia Allen to its Board of Directors Zenas BioPharma announces the appointment of Patricia Allen to its Board of Directors, on which she also will serve as Chair of the Audit Committee Bionical Solutions appoints Chief Technology Officer Bionical Solutions appoints Chief Technology Officer Bionical Solutions announces the appointment of Andrew Seward as Chief Technology Officer for the Digital business Nicox appoints Gavin Spencer as CEO Nicox appoints Gavin Spencer as CEO Spencer’s initial focus will be on securing financing to complete the Phase III trial of NCX 470, Denali Greenphire adds industry veteran Dan Shannon as new Chief Experience Officer Greenphire adds industry veteran Dan Shannon as new Chief Experience Officer Greenphire, a leading innovator in software solutions to improve clinical research site performance and participant satisfaction, announces the addition of healthcare... Curia appoints Steve Lavezoli as Vice President, Biologics Curia appoints Steve Lavezoli as Vice President, Biologics Curia, a leading contract research, development and manufacturing organisation, has appointed Steve Lavezoli as Vice President of Biologics Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors At its meeting on 22 February, Sanofi’s Board of Directors has decided to propose, on the occasion of its next General Shareholder Meeting to be held on April 30, 2024, the... Flexxbotics appoints Marc Lind, as CSO and CMO Flexxbotics appoints Marc Lind, as CSO and CMO His knowledge of manufacturing software will help Flexxbotics expand operations while continuing to extend its technology leadership in SaaS/Hybrid solutions AES Clean Technology appoints new Vice President of Engineering AES Clean Technology appoints new Vice President of Engineering Chris Barbieri will assume the position, focusing on streamlining the team’s processes and driving consistency PolTREG appoints Dan Shelly as Chief Business Development Officer PolTREG appoints Dan Shelly as Chief Business Development Officer Prof. Shelly will help build partnerships that will allow the company to commercialise their pipeline of cell therapies